BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31978720)

  • 1. Rare case of remission of a patient with small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) stage IV: Case report.
    Mathey MP; de Jolinière JB; Major A; Conrad B; Khomsi F; Betticher D; Devouassoux M; Feki A
    Int J Surg Case Rep; 2020; 66():398-403. PubMed ID: 31978720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.
    Callegaro-Filho D; Gershenson DM; Nick AM; Munsell MF; Ramirez PT; Eifel PJ; Euscher ED; Marques RM; Nicolau SM; Schmeler KM
    Gynecol Oncol; 2016 Jan; 140(1):53-7. PubMed ID: 26546963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings.
    Lu B; Shi H
    J Cancer; 2019; 10(1):223-237. PubMed ID: 30662543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome-A Systematic Review.
    Wens FSPL; Hulsker CCC; Fiocco M; Zsiros J; Smetsers SE; de Krijger RR; van der Steeg AFW; Zweemer RP; Baas IO; Roes EM; Looijenga LHJ; Gerestein CG; Mavinkurve-Groothuis AMC
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
    Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
    Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
    Witkowski L; Goudie C; Ramos P; Boshari T; Brunet JS; Karnezis AN; Longy M; Knost JA; Saloustros E; McCluggage WG; Stewart CJR; Hendricks WPD; Cunliffe H; Huntsman DG; Pautier P; Levine DA; Trent JM; Berchuck A; Hasselblatt M; Foulkes WD
    Gynecol Oncol; 2016 Jun; 141(3):454-460. PubMed ID: 26975901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
    Ramos P; Karnezis AN; Hendricks WP; Wang Y; Tembe W; Zismann VL; Legendre C; Liang WS; Russell ML; Craig DW; Farley JH; Monk BJ; Anthony SP; Sekulic A; Cunliffe HE; Huntsman DG; Trent JM
    Rare Dis; 2014; 2(1):e967148. PubMed ID: 26942101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
    Lin DI; Chudnovsky Y; Duggan B; Zajchowski D; Greenbowe J; Ross JS; Gay LM; Ali SM; Elvin JA
    Gynecol Oncol; 2017 Dec; 147(3):626-633. PubMed ID: 29102090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of a stage IIIC small-cell carcinoma of the ovary hypercalcemic subtype using multi-modality therapeutic approach.
    Qin Q; Ajewole VB; Sheu TG; Donohue R; Singh M
    Ecancermedicalscience; 2018; 12():832. PubMed ID: 29910829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.
    Wang Y; Chen SY; Karnezis AN; Colborne S; Santos ND; Lang JD; Hendricks WP; Orlando KA; Yap D; Kommoss F; Bally MB; Morin GB; Trent JM; Weissman BE; Huntsman DG
    J Pathol; 2017 Jul; 242(3):371-383. PubMed ID: 28444909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.
    Witkowski L; Goudie C; Foulkes WD; McCluggage WG
    Surg Pathol Clin; 2016 Jun; 9(2):215-26. PubMed ID: 27241105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.
    Witkowski L; Donini N; Byler-Dann R; Knost JA; Albrecht S; Berchuck A; McCluggage WG; Hasselblatt M; Foulkes WD
    Fam Cancer; 2017 Jul; 16(3):395-399. PubMed ID: 27866340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
    Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
    J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.
    Sanders BE; Wolsky R; Doughty ES; Wells KL; Ghosh D; Ku L; Pressey JG; Bitler BB; Brubaker LW
    Gynecol Oncol Rep; 2022 Dec; 44():101077. PubMed ID: 36249907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
    Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
    Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual Aspects of Small Cell Carcinoma of the Ovary of Hypercalcaemic Type: Retained SMARCA4 Immunohistochemical Staining and Positive Staining With TLE1.
    Mazibrada J; Jayatunge N; Domecq C; Witkowski L; Croce S; Foulkes WD; McCluggage WG
    Am J Surg Pathol; 2023 Nov; 47(11):1261-1266. PubMed ID: 37345679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
    Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
    J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Somatic Mutations of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: A Case Report.
    Aoyagi Y; Kai K; Nishida H; Aso S; Kobayashi E
    Cureus; 2024 May; 16(5):e60802. PubMed ID: 38903333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature.
    Rao V; Bauer F; Vredenburgh JJ
    Conn Med; 2016 Oct; 80(9):529-532. PubMed ID: 29772136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.